Chapter 36: Astrocytes and Parkinson's disease
- 1 January 1992
- book chapter
- Published by Elsevier
- Vol. 94, 429-436
- https://doi.org/10.1016/s0079-6123(08)61770-7
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Astrocytes as a primary locus for the conversion MPTP into MPP+Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988
- Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+Neuroscience Letters, 1987
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural markerJournal of Comparative Neurology, 1981
- Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleusThe Anatomical Record, 1966